Prescribing overview
Suppresses estrus in mares for reproductive-cycle management.
Veterinary assessment of ovarian activity and uterine health guides the breeding plan.
Key prescribing checks
- Review the full product-specific safety section and the patient’s complete treatment plan.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Horses
US veterinary product labelEstrus suppression
Patient and indication restrictions apply.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Progestational activity suppresses estrus; withdrawal permits return of estrus in suitable mares.
Absorption, distribution, metabolism and elimination
The reviewed label does not establish a quantitative equine pharmacokinetic regimen.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Regu-Mate
US Oral solution for mares label.
Contraindications · when not to use
- Do not use in mares with current or previous uterine inflammation.
Precautions & monitoring
- Not for food-chain horses. Skin absorption can seriously affect handlers; pregnant people must not handle it.
Selected safety information; not a complete interaction assessment.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Existing uterine inflammation may worsen; developmental changes were observed in offspring in reproductive safety studies.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
Select a regimen from the current exact-product label with the prescribing veterinarian; no calculator regimen is supplied for this entry.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Compare with other medications and check species →
Regu-Mate
US Oral solution for mares label.
- No complete drug-interaction assessment is established here.
Monitoring
Track cycle response and reproductive examinations.
Client counseling
Use vinyl, nitrile or neoprene gloves; latex is inadequate. Review the full human-handler exclusion list.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Close securely at or below room temperature; decontaminate equipment and surfaces.
Brands, formulations & ingredient identity
Active ingredients
Altrenogest
Other searchable names: Regu-Mate · Regumate
This reference covers the named US product and route; other formulations need separate verification.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Regu-Mate
- Formulation
- Oral solution for mares
- Label / product scope
- Horses
US labeled presentation; verify the current package.
Product label / source ↗References & review status
Clinical reference updated October 27, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
Search another medication or supplement →